Last updated: January 12, 2024
Sponsor: Jingye Tai
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dysrhythmia
Heart Defect
Fast Heart Rate (Tachycardia)
Treatment
Non-invasive vagus nerve stimulation
Clinical Study ID
NCT06219343
ES-2023-175-03
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The relevant diagnostic criteria in the Guidelines for the Diagnosis and Treatment ofSupraventricular Tachycardia (svt) need to be met.
- All need to be free of psychiatric abnormalities, verbal communication disorders, andhave good compliance.
- The patients and their families gave informed consent and signed the informed consentform.
Exclusion
Exclusion Criteria:
- Does not meet the relevant diagnostic criteria in the Guidelines for the Diagnosis andTreatment of Supraventricular Tachycardia (svt).
- Mental anomalies, verbal communication disorders, poor adherence
- Those who do not consent to participate in this clinical trial
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Non-invasive vagus nerve stimulation
Phase:
Study Start date:
January 10, 2023
Estimated Completion Date:
December 30, 2024
Study Description
Connect with a study center
Ai-lan Chen
Guangzhou, Guangdong 510000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.